Why the FDA Refuses Imports: What 210,000+ Refusal Records Teach Shippers

Last updated October 22, 2026·Data: FDA Import Refusals, fetched 2026-10-20

Short answer: an FDA refusal is not a duty dispute — it means your goods arrived, were examined, and failed an admissibility requirement under the Food, Drug, and Cosmetic Act. We parsed all 210,625 records in the FDA import refusal database (spans 2016-10-03 to 2026-10-15); in the trailing twelve months starting 2025-10-01, 48,849 refused lines were recorded across 132 origin markets. This page shows where refusals concentrate, what the charge codes look like, and the paperwork sequence that gets refused goods moving again.

Most trade compliance content treats tariffs as the whole story. But a container can clear Customs perfectly and still never reach your warehouse: the FDA regulates roughly twenty cents of every dollar Americans spend, and its admission decisions run on a separate track from CBP's duty collection. A tariff planner who ignores the FDA layer is planning half the risk.

How an import becomes a refusal

The machinery has four stages. First, prior notice: before food arrives, the importer or broker must file prior notice so the FDA knows what is coming. Second, review and examination: entries are screened against the agency's automated systems, and some are flagged for physical examination. Third, a detention notice issues when the goods may violate the law — at that point you have a working window to supply evidence, samples or corrected labeling. Fourth comes the decision: release, or refusal. A refusal means the agency judged the shipment inadmissible; the record then lands in the database this page is built from. Rejected goods are not destroyed automatically — within specified timelines the exporter normally must re-export or destroy them, or pursue reconditioning under supervision.

Two practical consequences follow. Because detention happens after arrival, your landed-cost math was already spent: ocean freight, demurrage and port storage accrue while the case sits. And because the refusal is recorded against the firm and product, repeat problems compound — a history of violations raises the odds that future entries are flagged for exam in the first place.

The monthly shape of the problem

The twelve most recent complete months, recomputed from the raw database at generation time (2026-10 is still filling and shows 2,272 lines by the dataset cutoff, so it is excluded below):

MonthRefused lines
2025-103,592
2025-113,373
2025-122,496
2026-012,430
2026-022,336
2026-032,551
2026-043,398
2026-055,358
2026-064,054
2026-075,436
2026-084,288
2026-099,537
Source: https://datadashboard.fda.gov/imports/refusals/default.aspx (fetched 2026-10-20).

The series is noisy but persistent: even the quietest month in the window carries thousands of refused lines. The most recent full month in the dataset, September 2026, set the window high at 9,537 refused lines — worth checking whether your category appears in the recent surge before you finalize a sourcing commitment.

Where refusals concentrate

Ranked by origin market over the trailing twelve months:

Origin marketRefused lines% share
Sweden15,22531.2%
India5,89212.1%
Denmark4,6499.5%
China2,5865.3%
Mexico2,4305.0%
Poland1,8123.7%
Czech Republic1,1962.4%
South Korea1,1672.4%
Canada9251.9%
Guatemala8041.6%
Source: https://datadashboard.fda.gov/imports/refusals/default.aspx (fetched 2026-10-20).

Read this table as a documentation-quality signal, not a quality verdict on entire nations. The top origins are the largest food, cosmetic and device exporters precisely because they ship the most regulated volume; the actionable unit is the supplier and the product line, not the country. Still, if you source a regulated category from a top-origin market, assume exam probability is real and paper your compliance file before sailing, not after detention.

Which product lines dominate

Grouping the trailing window by FDA product-code family (the first two characters of each record's product code) shows what actually gets refused — and why recent headlines can be misleading:

FDA product-code familyRefused linesExample product text
9824,596Nicotine Pouch
662,249Ultraviolet Screen/Sunscreen N.E.C.
611,617Semaglutide (Anti-Diabetic)
541,366Herbals & Botanicals (Not Teas), N.E.C.
071,286Corn Chips, Fried
Source: https://datadashboard.fda.gov/imports/refusals/default.aspx (fetched 2026-10-20).

The single most consequential recent shift hides in that table: nicotine pouches. A wave of refusals against Swedish and Danish manufacturers of modern oral nicotine products pushed tobacco-adjacent codes to the top of the trailing-twelve-month census, and it is why a mid-sized Nordic economy outranks China in the origin table above. Before that wave, India's food exports (spice, prepared foods, ingredients) and China's regulated-goods mix dominated the same ranking for years — a reminder that refusal tables move with enforcement campaigns and product trends, so point-in-time screenshots age quickly.

Where the work happens: FDA divisions

The database tags each refusal with the reviewing division. The concentration tells you where regulatory friction will appear:

FDA import divisionRefused lines% share
Division of Northeast Imports (DNEI)21,23143.5%
Division of Southeast Imports (DSEI)19,31739.5%
Division of West Coast Imports (DWCI)3,8848.0%
Division of Southwest Imports (DSWI)2,6865.5%
Source: https://datadashboard.fda.gov/imports/refusals/default.aspx (fetched 2026-10-20).

Remaining share: smaller district offices (New Orleans, Los Angeles, Florida and others).

What the charge codes mean

Each refusal row lists one or more numeric charge identifiers; across the trailing window they appear 85,429 times in total. The five most frequent are 3842 (19,076 lines), 3843 (17,318 lines), 75 (7,776 lines), 3854 (6,956 lines), 118 (4,398 lines). The numbers map to violation families — food safety provisions, labeling requirements, registration and process-filing gaps — but the authoritative wording attaches to each case's notices, and the agency publishes the identifier catalog rather than embedding labels in the extract. Practical advice: quote the exact charge numbers in any correspondence and pull their definitions from the official catalog before responding; brokers see these sequences weekly, and a correct response targeted at the actual charge family is what separates a quick reconditioning from a re-export order.

8,496 distinct facilities appear in the trailing window alone — the universe of firms touching this process is enormous, which is why the agency leans on systematic controls (registration, FSVP-style supplier verification, process filings) instead of fixing individual shipments.

Preventing the refusal, step by step

  1. Verify registration scope. Food facilities, drug establishments and device exporters each have distinct registration and listing duties, and a missing registration is itself a refusal charge. Confirm the entity numbers exist and are current before the commercial invoice is cut.
  2. Fix labeling at artwork stage. Ingredient declarations, net quantity, language and nutrition panels are cheap to correct in prepress and expensive to correct in a bonded warehouse. Compare the master label against the regulation for the US market, not the one approved for other destinations.
  3. File prior notice correctly. Match the entry data exactly; mismatches between prior notice and the entry create exam triggers even for compliant goods.
  4. Prepare the detention response early. When a Detention Without Physical Examination or notice arrives, the clock matters: gather specifications, test reports and process evidence immediately, and decide quickly whether reconditioning, re-export or abandonment minimizes loss.
  5. Price the risk into landed cost. Expected exam delay, storage and re-submission costs belong in your quoting model the way duty does — run scenarios through the landed-cost calculator so a detained-lot scenario is priced, not suffered.

A five-minute workflow before you confirm an order

  1. Browse the refusals dataset page and search your supplier's name and FEI among recent refusals.
  2. Check the product family against the monthly trend above — surging categories deserve extra documentary margin.
  3. Cross-check duty-side exposure separately: refusals do not remove tariffs, and Chapter 99 add-ons still apply to released lots (see our guides on tariff stacking).
  4. Put monitoring on the supplier: our monitoring plans watch trade-data signals so a deteriorating compliance record surfaces before your next deposit payment.

Methodology and data freshness

All counts derive from our working copy of the FDA Import Refusals detail table (210,625 rows, 210,625 with parseable refusal dates spanning 2016-10-03 to 2026-10-15). The pipeline stores each row with its fetch timestamp and deduplicates on the shipment key, so regenerating this page after a refresh updates every figure automatically. Country attribution uses the final comma field of the firm address; shares are computed against the trailing twelve-month subset. Nothing here is legal advice — for binding decisions consult your broker, customs counsel or the FDA division of record.

Can an FDA import refusal be reversed?

Yes, sometimes. After a refusal the exporter or importer chooses one of three lanes: reconditioning under FDA supervision (fixing the violation so the goods become admissible), re-export, or destruction. Reconditioning is realistic for correctable defects such as labeling or incomplete process filings; safety-based violations usually end in re-export or destruction. The refusal record itself remains in the database either way.

What is the difference between FDA detention and refusal?

Detention is the intermediate stage: the FDA holds goods it believes may be in violation while the importer supplies evidence, samples or corrected documentation. Most detentions resolve into release. A refusal is the terminal decision that the goods are inadmissible as presented, recorded in the refusal database this article analyzes.

Which products get refused by the FDA most often?

It moves with enforcement waves. Historically food dominates - seafood, produce and processed foods head the tables year after year - but our trailing-twelve-month recomputation shows tobacco-adjacent nicotine products surging past every food family, driven by refused pouch shipments from Northern European manufacturers. Cosmetics, drugs and medical devices round out the top families; check the live table above rather than any cached snapshot.

Does one refusal hurt future shipments?

It can. Refusal histories feed the risk screens that decide which entries are flagged for exam, and repeated violators can face Detention Without Physical Examination listings ("import alerts"), where the burden shifts to the importer to prove admissibility on every entry until the alert is removed. Keeping a clean documentary record and responding to detentions inside the deadlines is how exporters stay off those lists.

Where does the data on this page come from?

From the FDA's own import refusals dashboard extract, mirrored into our database with per-row fetch timestamps and source URLs. Every figure on this page is recomputed from that working copy at generation time, so the numbers always reflect the latest refresh rather than a hand-copied snapshot.